Question read the case study and answer the following question

A Matter of Life and Death

We should do everything possible to minimize the damage of the Covid-19 pandemic, but it's also time to decide how to best allocate scarce medical resources.

The Covid-19 pandemic has evolved rapidly. The dramatic increase in patients, particularly those with severe illness, has already overwhelmed the health system in many locales and will likely soon do so in many others, resulting in shortages of medical supplies, infrastructure, and staff.

Given the speed with which the coronavirus is straining health care resources, rationing is likely inevitable. The question, then, is how to allocate resources during an emergency. Which patients should get priority when allocating ventilators or intensive-care beds? Once a vaccine is developed, who should receive the first batches while production and delivery are being scaled?

Establishing a legitimate prioritization strategy before rationing may be especially important in decentralized health systems with substantial private control of hospitals and other health care facilities; private health enterprises are likely to have a number of competing interests beyond providing optimal care, including revenue and profits as well as the preferences of board members, professional staff, and patient populations.

Business-as-usual approaches to prioritization of health resources fail to meet society's expectations for fairness, justice, and efficiency. Given the absence of an adequate pre-existing framework for Covid-19- related rationing decisions, there is a clear need to develop an ethical prioritization mechanism based on socially accepted principles...

Now read on:

https://www.imf.org/external/pubs/ft/fandd/2020/04/allocating-scarce-medical-resources-during-the-COVID19-pandemic-bloom.htm

With the aid of a graph, explain the concepts of scarcity, choice and opportunity cost in the context of the

case study given to you. Also briefly discuss an ethical approach to the prioritization and allocation of

resources in the context of the provision of Covid19 vaccines both globally and nationally.